4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-023494
Chief Scientific Officer sold 7,950 shares at $60.00 ($477,000)
- Chief Scientific Officer acquired 7,950 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lachey Jennifer · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-04 | Exercise or conversion : show line 1 in the form | +7,950 | $0.30 | $2,385 | 93,650 | D |
| 2022-04-04 | Sale : show line 2 in the form | −7,950 | $60.00 | $477,000 | 85,700 | D |
| Open-market sales · 7,950 sh · avg $60.00 · $477,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-04 | Exercise or conversion : show line 3 in the form of Shares Employee Stock Option (right to buy) | −7,950 | 76,705 | D |
Loading xslF345X03/doc4.xml…